81 participants
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2022-09-06
- Completion:
- 2026-07-17
Conditions
- Cardiomyopathy
- Heart Failure With Preserved Ejection Fraction (HFpEF)
- Obesity
Interventions
- DRUG
- BEHAVIORAL
No Results Yet